secwatch.observer — SEC 8-K summary
======================================

Issuer:     Revolution Medicines, Inc. (RVMD)
CIK:        0001628171
Form:       8-K
Filed at:   2023-11-01T23:59:59+00:00
Accession:  0001193125-23-267696
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revolution Medicines sets final merger exchange ratio at 0.1112; ISS/Glass Lewis back deal
--------------------------------------------------------------------------------

- Final exchange ratio: 0.1112 RVMD shares per EQRx share, up from illustrative 0.0734.
- ISS and Glass Lewis recommend RVMD stockholders vote FOR the share issuance.
- Merger expected to add ~$1.1B net cash (~$20 per share issued); close targeted Nov 2023.
- RVMD to issue ~55M shares (excl. warrants/earn-outs) for the acquisition.
- RVMD special meeting of stockholders scheduled for November 8, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628171/000119312523267696/0001193125-23-267696-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628171/000119312523267696/d527979d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-267696

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer